Fair Value Measurements (Details) - Schedule of fair value of the Company's derivative liabilities - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Fair Value Measurements (Details) - Schedule of fair value of the Company's derivative liabilities [Line Items]
Beginning balance	$ 8,355
Issuance of convertible debentures		2,077
Increase in fair value included in earnings		6,278
Ending balance	3,745	8,355
Transferred to equity on debt conversion	(2,921)
Transferred to equity on RSU issuance	(5)
Transferred from equity on recognition of derivative liability	314
Fair value of warrants issued	534
Decrease in fair value included in earnings	(2,532)
Conversion feature derivative liability [Member]
Fair Value Measurements (Details) - Schedule of fair value of the Company's derivative liabilities [Line Items]
Beginning balance	8,355
Issuance of convertible debentures		2,077
Increase in fair value included in earnings		6,278
Ending balance	3,472	8,355
Transferred to equity on debt conversion	(2,921)
Transferred from equity on recognition of derivative liability
Fair value of warrants issued
Decrease in fair value included in earnings	(1,962)
Common stock derivative liability [Member]
Fair Value Measurements (Details) - Schedule of fair value of the Company's derivative liabilities [Line Items]
Beginning balance
Issuance of convertible debentures
Increase in fair value included in earnings
Ending balance	273
Transferred to equity on debt conversion
Transferred to equity on RSU issuance	(5)
Transferred from equity on recognition of derivative liability	314
Fair value of warrants issued	534
Decrease in fair value included in earnings	$ (570)